To the best of our knowledge, ours is the first study that links ABCB1 polymorphisms with the treatment outcome of patients with COVID-19, although some ambiguities about the effect of these polymorphisms on the transport capacity of the ABC transporter still remain. This evidence concerns the gene ABCG2 and COVID-19.